Design, Rationale, and Methods of the INITIATE-HFrEF Trial: ARNI and SGLT2 Inhibitors Sequencing in HFrEF.
- DOI
- 10.1016/j.jacadv.2026.102589
- Published
- 2026 Mar
- Container
- JACC. Advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacadv.2026.102589,
title = {Design, Rationale, and Methods of the INITIATE-HFrEF Trial: ARNI and SGLT2 Inhibitors Sequencing in HFrEF.},
author = {Ferreira JP and Oliveira AC and Saraiva F and Pereira-Sousa I and Azevedo R and Angélico-Gonçalves A and Grijó C and Santos MP and Gavina C and Santos M and Fontes-Carvalho R and Pimenta J and Leite-Moreira A and Vasques-Nóvoa F and INITIATE-HFrEF Investigators},
year = {2026},
journal = {JACC. Advances},
doi = {10.1016/j.jacadv.2026.102589},
url = {https://doi.org/10.1016/j.jacadv.2026.102589}
}RIS
TY - JOUR TI - Design, Rationale, and Methods of the INITIATE-HFrEF Trial: ARNI and SGLT2 Inhibitors Sequencing in HFrEF. AU - Ferreira JP AU - Oliveira AC AU - Saraiva F AU - Pereira-Sousa I AU - Azevedo R AU - Angélico-Gonçalves A AU - Grijó C AU - Santos MP AU - Gavina C AU - Santos M AU - Fontes-Carvalho R AU - Pimenta J AU - Leite-Moreira A AU - Vasques-Nóvoa F AU - INITIATE-HFrEF Investigators PY - 2026 JO - JACC. Advances DO - 10.1016/j.jacadv.2026.102589 UR - https://doi.org/10.1016/j.jacadv.2026.102589 ER -
APA
JP, F., AC, O., F, S., I, P., R, A., A, A., C, G., MP, S., C, G., M, S., R, F., J, P., A, L., F, V., & Investigators, I. (2026). Design, Rationale, and Methods of the INITIATE-HFrEF Trial: ARNI and SGLT2 Inhibitors Sequencing in HFrEF.. JACC. Advances. https://doi.org/10.1016/j.jacadv.2026.102589
Source records
- pubmed · retrieved 2026-09-27T11:59:25.359Z